George J. Kahaly

TL;DR: In mild GO, a watchful strategy is usually sufficient, but a 6-month course of selenium supplementation is effective in improving mild manifestations and preventing progression to more severe forms, and shared decision-making is recommended for selecting second-line treatments.

TL;DR: This document is dedicated to the memory of MarkPrummel (1956–2005), one of the founders of EUGOGO, who greatly contributed to expanding the understanding of clinical and therapeutic aspects of GO.

TL;DR: T(3) leads to an increase in the speed of diastolic relaxation, which is caused by the more efficient pumping of the calcium ATPase of the sarcoplasmic reticulum.

TL;DR: If a patient relapses after completing a course of ATD, definitive treatment is recommended; however, continued long-term low-dose MMI can be considered, and steroid prophylaxis is warranted in Graves’ patients with mild/active orbitopathy receiving RAI.

TL;DR: Selenium administration significantly improved quality of life, reduced ocular involvement, and slowed progression of the disease in patients with mild Graves' orbitopathy.